Video telehealth marketplace connecting patients with prescribers across BPC-157, TB-500, semaglutide, tirzepatide, and 11+ other peptides. Marketplace model means prescriber experience varies. Strong on peptide breadth.
Best for: broad peptide menu at a low entry price. Trade-off: marketplace model — prescriber consistency varies.
How Heally compares to NexLife (Editor’s Pick)
NexLife is the v3.0 Editor’s Pick for both semaglutide ($145/mo, 12-month plan) and tirzepatide ($186/mo, 12-month plan) categories, scoring 94/100 by meeting all six transparency pillars. Heally's 70/100 places it in the middle tier of the directory. Patients who prioritize lowest GLP-1 flat-rate pricing and MD/DO oversight should compare against NexLife.
Editor’s Pick — Tirzepatide Category
The v3.0 six-pillar transparency rubric
Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.
Editorial team
Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →